Diabetic macular edema: new concepts in patho-physiology and treatment. - Wikidata - thesis-toulmin - TriplyDB

Diabetic macular edema: new concepts in patho-physiology and treatment.

Diabetic macular edema: new concepts in patho-physiology and treatment.

http://www.wikidata.org/entity/Q33713517

about

Diabetic Macular Edema Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.Exercise training prevents increased intraocular pressure and sympathetic vascular modulation in an experimental model of metabolic syndrome.Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.Vascular Endothelial Growth Factor and Diabetic Retinal Disease.Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse Corticosteroid Treatment in Diabetic Macular Edema.Comparison of Cysts in Red and Green Images for Diabetic Macular Edema Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p Diabetic Retinopathy: Vascular and Inflammatory Disease.Recent developments in ocular drug delivery.Malathion increases apoptotic cell death by inducing lysosomal membrane permeabilization in N2a neuroblastoma cells: a model for neurodegeneration in Alzheimer's disease.Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.Diabetic retinopathy: current understanding, mechanisms, and treatment strategies Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema.A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.En Face Doppler Optical Coherence Tomography Measurement of Total Retinal Blood Flow in Diabetic Retinopathy and Diabetic Macular Edema.Ischemic Retinopathies: Oxidative Stress and Inflammation.Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy.Cystoid edema, neovascularization and inflammatory processes in the murine Norrin-deficient retina.Role of Inflammation in Diabetic Retinopathy.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography.Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy

P2860

Q26749438-79DDFB2B-74FE-44B6-A02F-BC8575372AA9 Q26775853-37DB4AB6-7C05-4A20-A9CF-458DCDE7AB66 Q27007119-3026C990-AC28-4FAB-8AEB-32C1BD5DD22C Q28082140-32C90628-EDBC-4A63-9EA4-C76D41B19D24 Q31018013-200D7585-3DAB-4BE1-A0EB-6D23E2FDDE3B Q35565237-B6546346-DAFB-4E73-8DF0-9E50FF360A24 Q35870506-660A4527-AA6B-4C81-8420-4A84C789DB53 Q35950867-895494D3-15DC-4DF8-BEBC-1596C7E4F0DA Q36297613-2CDD314F-E1DC-4073-BD4B-91B182AAC415 Q36376302-2FD451C1-7E23-4A87-A793-E91D1FA2EFF2 Q36409906-BE02A2D9-7540-4A39-9722-8E0A843FBD2D Q37607065-4A76939A-4F8F-4CCF-8D91-BA0932FF512B Q37634192-822E5906-444C-4D41-B57C-6A8828E7E1D9 Q38542115-959D873A-34CB-4415-8B1A-93357A1B23C3 Q38603354-0584A32C-3121-4A5A-A0A5-89A6309001C4 Q38795118-5F87D6DD-B89C-4239-BF12-31B03A7CF19C Q38903822-9CF123B9-5CB1-48A5-857B-AC748681D8EA Q39292954-D924F148-42C6-42CF-A210-A39A89733768 Q39445950-D1C28324-27C2-4DA8-B6A9-1FDCC277B6FF Q43148680-5D3B1721-E482-4DC5-9F87-869478F16EFE Q47230436-C6E7AB0D-5B84-4D5B-9FF3-B17ABFB5ED32 Q47860335-2097D696-20D7-4EE9-932E-05D0B73EE760 Q48095108-2CE51EE2-E3FE-458F-8D45-036776ED5861 Q51366968-86E6AD70-C86D-4A5D-BAC1-290663618BCF Q52309509-F8420272-696C-437D-B712-868A0A914EEB Q52589103-AA6161EB-8220-4350-AA3F-5402C4B9377F Q52642996-D7F18BF2-E1A5-4256-896F-243C533924DE Q53850946-20462238-ECE2-43A9-A7C4-9FFF377AA867 Q58616565-F3D057A8-64E4-400A-9566-D37C8A79419E

P2860

Diabetic macular edema: new concepts in patho-physiology and treatment.

http://www.wikidata.org/entity/Q33713517

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Diabetic macular edema: new concepts in patho-physiology and treatment.

@ast

Diabetic macular edema: new concepts in patho-physiology and treatment.

@en

type

label

Diabetic macular edema: new concepts in patho-physiology and treatment.

@ast

Diabetic macular edema: new concepts in patho-physiology and treatment.

@en

prefLabel

Diabetic macular edema: new concepts in patho-physiology and treatment.

@ast

Diabetic macular edema: new concepts in patho-physiology and treatment.

@en

P1433

Q33713517-93D3432B-F79F-444A-9B97-CCD269CFCBC5

P1476

Q33713517-910F6E1A-821B-40C1-9254-0D23B9F505C7

P2093

Q33713517-16154C18-2844-4437-AC58-61754CF93A04

Q33713517-5FE38882-769B-4479-B482-31E7124B699A

Q33713517-6293D13D-C9EA-42E0-A91A-9E6ADD91E4DF

Q33713517-6506DA35-F716-4B7E-BE4C-4BD97210C1D5

Q33713517-84CC43E2-57DD-40FC-941A-DBB87873EB6C

P2860

Q33713517-03087B66-73D0-4610-B3FE-CC7FB19C4C2B

Q33713517-030D472C-B105-455A-9731-A447729CC452

Q33713517-077D1BED-B6B0-4D8C-B353-6FC1AF406FF0

Q33713517-08AE160F-0409-4C20-B3B5-549353B9CB3E

Q33713517-0B7F10B2-887F-45DD-B9BD-F86628658F5E

Q33713517-0BB15720-D30E-4FD5-A12B-82FA48528110

Q33713517-0CE3AD3D-3A0B-4DBE-BD8F-3208F0FA858D

Q33713517-0E4C9AFA-7B87-4E5A-A936-BB0DE983B629

Q33713517-12F88840-798E-4A55-9A63-FCAE91D14536

Q33713517-15920FA4-0896-481F-A5DC-B8A09348A154

P2888

Q33713517-793CF65D-531D-451A-A0ED-2D14C2EA5D3E

P304

Q33713517-6660EE95-7BAF-45C3-B654-62EF110E1234

P31

Q33713517-0ECE244C-3174-4DD0-9CBF-332E3416718A

P356

Q33713517-9AAEF5D9-A904-495C-851E-464B71951D2E

P478

Q33713517-F0034096-20F7-4F9C-98D4-1D200317D87E

P577

Q33713517-281A6994-2D93-420F-9EA6-F723EF448745

P5875

Q33713517-00A588C1-6AAF-44C2-99C7-B6F3AB1C6DFD

P6179

Q33713517-E1D3A5D0-60F2-43D0-8DDE-460F83702690

P698

Q33713517-6A33CB54-C599-4F54-800D-0454AEAC1E06

P932

Q33713517-BCBFCBE0-A6FC-45EE-833B-A89D78B61FE7

P356

P1433

Cell & Bioscience

P1476

Diabetic macular edema: new concepts in patho-physiology and treatment.

@en

P2093

Huan Zeng

http://www.w3.org/2001/XMLSchema#string

Mark C Gillies

http://www.w3.org/2001/XMLSchema#string

Ningli Wang

http://www.w3.org/2001/XMLSchema#string

Shian Bao

http://www.w3.org/2001/XMLSchema#string

Xinyuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The biology of VEGF and its receptors

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

Tight junction proteins

Aldose reductase localization in human retinal mural cells

Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.

Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway

Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy

The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

The biology of vascular endothelial growth factor

P2888

P304

27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2045-3701-4-27

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263320811

http://www.w3.org/2001/XMLSchema#string

P6179

1006126669

http://www.w3.org/2001/XMLSchema#string

P698

24955234

http://www.w3.org/2001/XMLSchema#string

P932

4046142

http://www.w3.org/2001/XMLSchema#string